A novel Epstein-Barr virus-latent membrane protein-1-specific T-cell receptor for TCR gene therapy.

about

A novel Epstein-Barr virus-latent membrane protein-1-specific T-cell receptor for TCR gene therapy.

Item

http://www.wikidata.org/entity/Q47549907

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

A novel Epstein-Barr virus-lat ...... receptor for TCR gene therapy.

@en

A novel Epstein-Barr virus-lat ...... receptor for TCR gene therapy.

@nl

type

Item

label

A novel Epstein-Barr virus-lat ...... receptor for TCR gene therapy.

@en

A novel Epstein-Barr virus-lat ...... receptor for TCR gene therapy.

@nl

prefLabel

A novel Epstein-Barr virus-lat ...... receptor for TCR gene therapy.

@en

A novel Epstein-Barr virus-lat ...... receptor for TCR gene therapy.

@nl

P1476

A novel Epstein-Barr virus-lat ...... receptor for TCR gene therapy.

@en

P2093

A-Ri Shin

http://www.w3.org/2001/XMLSchema#string

Hyun-Il Cho

http://www.w3.org/2001/XMLSchema#string

Hyun-Joo Lee

http://www.w3.org/2001/XMLSchema#string

Hyun-Jung Sohn

http://www.w3.org/2001/XMLSchema#string

Ji-Na Won

http://www.w3.org/2001/XMLSchema#string

Tai-Gyu Kim

http://www.w3.org/2001/XMLSchema#string

Un-Hee Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

Cancer regression in patients after transfer of genetically engineered lymphocytes

Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia

Characterization of latent membrane protein 2 specificity in CTL lines from patients with EBV-positive nasopharyngeal carcinoma and lymphoma.

T cell re-targeting to EBV antigens following TCR gene transfer: CD28-containing receptors mediate enhanced antigen-specific IFNgamma production.

Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapy

P2888

bjc.2017.475

P31

scholarly article

P356

10.1038/BJC.2017.475

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2018-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29360818

http://www.w3.org/2001/XMLSchema#string

P932

5830600

http://www.w3.org/2001/XMLSchema#string